Found 5 matching trials
Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)
PHASE2This is a phase II multicenter, open-label study designed to investigate th...
Location
Multiple Locations
A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia
PHASE2Patients with chronic myeloid leukemia in imatinib induced CHR are randomiz...
Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy
PHASE3The study is controlled and randomized in Philadelphia-positive chronic mye...
Location
Department of Hematology, Sheba Medical Center
Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia
PHASE2The treatment of CML and the expected survival has been revolutionised sinc...
Location
Royal Adelaide Hospital
Imatinib or Nilotinib With Pegylated Interferon-ฮฑ2b in Chronic Myeloid Leukemia
PHASE2To investigate whether patients with chronic-phase chronic myeloid leukemia...
Location
Universtiy of Michigan